You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thioguanine

Showing 26 - 50 of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in Baltimore, Houston, Seattle (Allopurinol)

Completed
  • Acute Lymphoblastic Leukemia (ALL)
  • Baltimore, Maryland
  • +2 more
Jun 17, 2022

Adverse Drug Reaction Trial in Worldwide (Pharmacogenomic testing)

Completed
  • Adverse Drug Reaction
  • Pharmacogenomic testing
  • Vienna, Austria
  • +6 more
Apr 15, 2022

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +21 more
  • Birmingham, Alabama
  • +219 more
Sep 15, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Chemosensitivity Assay
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 29, 2022

Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

Active, not recruiting
  • Lymphoblastic Leukemia, Acute, Adult
  • +2 more
  • Brno, Czechia
  • +4 more
Aug 3, 2022

Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Worldwide (3-Dimensional Conformal Radiation

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Childhood B Acute Lymphoblastic Leukemia
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Birmingham, Alabama
  • +235 more
Jun 11, 2021

Pancreatitis, IBD Trial in Jerusalem (Azathioprine)

Withdrawn
  • Pancreatitis
  • Inflammatory Bowel Diseases
  • Jerusalem, Israel
    Shaare Zedek
Mar 17, 2021

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Worldwide

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Birmingham, Alabama
  • +233 more
Apr 2, 2021

Leukemia Trial in Worldwide (biological, drug, procedure)

Unknown status
  • Leukemia
  • anti-thymocyte globulin
  • +21 more
  • Boston, Massachusetts
  • +12 more
Jul 29, 2019

Lymphoblastic Lymphoma, Childhood Trial in Worldwide (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • Lymphoblastic Lymphoma, Childhood
  • Graz, Austria
  • +222 more
Dec 13, 2022

Indian Children With Acute Lymphoblastic Leukemia

Not yet recruiting
  • ALL, Childhood
  • +7 more
    • New Delhi, India
    • +1 more
    Aug 22, 2022

    Crohn's Disease Trial in Lucknow (Artesunate, Curcumin, Placebo A)

    Not yet recruiting
    • Crohn's Disease
    • Lucknow, Uttar Pradesh, India
      Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIM
    Jan 20, 2021

    Leukemia, Acute Lymphoblastic Trial in Worldwide (Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab

    Recruiting
    • Leukemia, Acute Lymphoblastic
    • Omitted Doxorubicin
    • +5 more
    • Brussels, Belgium
    • +100 more
    Dec 12, 2022

    Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

    Recruiting
    • Acute Myeloid Leukemia
    • A arm (DA-90)
    • +3 more
    • New York, New York
    • +9 more
    Sep 30, 2021

    Leukemia, Precursor-B Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Cytarabine, Daunorubicin,

    Terminated
    Has Results
    • Leukemia
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    May 9, 2018

    Adverse Drug Reaction Trial in Indianapolis (Pharmacogenetic Intervention Arm (pharmacogenetic testing))

    Completed
    • Adverse Drug Reaction
    • Pharmacogenetic Intervention Arm (pharmacogenetic testing)
    • Indianapolis, Indiana
      Eskenazi Health System
    Jan 6, 2021

    Leukemia Trial in Hong Kong (dexamethasone, mercaptopurine, methotrexate)

    Completed
    • Leukemia
    • Hong Kong, China
    • +1 more
    Mar 4, 2020

    Acute Lymphoblastic Leukemia, Pediatric Trial in Tanjin (6-mercaptopurine, Standard treatment, Individualized treatment)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • Tanjin, Tianjin, China
      State Key Laboratory of Experimental Haematology, Department of
    Jan 10, 2020

    Breast Cancer, Ovarian Cancer Trial in Oxford (6-Mercaptopurine, Methotrexate)

    Completed
    Has Results
    • Breast Cancer
    • Ovarian Cancer
    • Oxford, United Kingdom
      Churchill Hospital
    Jun 28, 2019

    Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

    Completed
    Has Results
    • Lymphoma
    • Birmingham, Alabama
    • +175 more
    Jul 24, 2019

    Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Tumors Trial run by the NCI (75 approved agents, COXEN)

    Completed
    Has Results
    • Urothelial Carcinoma
    • +2 more
    • 75 approved agents
    • COXEN
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 14, 2020

    Hepatic Veno-Occlusive Disease, Nephroblastoma, Acute Lymphoblastic Leukemia Trial in France (Blood test for genetic analysis)

    Unknown status
    • Hepatic Veno-Occlusive Disease
    • +2 more
    • Blood test for genetic analysis
    • Amiens, France
    • +15 more
    Nov 15, 2019

    Young Acute Lymphoblastic Leukemia in Remission

    Completed
    • Childhood Acute Lymphoblastic Leukemia in Remission
    • Compliance Monitoring
    • +5 more
    • Birmingham, Alabama
    • +134 more
    Jul 1, 2020

    Leukaemia,Lymphoblastic Trial in GuangZhou (Vincristine, Daunorubicin, Pegaspargase)

    Unknown status
    • Leukaemia,Lymphoblastic
    • GuangZhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jun 16, 2017